GIC Eyes Rs 42,000-43,000 Crore Premium Following Q1 Results
General Insurance Corp. can return to more modest growth rates for the remainder of the current financial year despite a strong performance in the first quarter, Chairperson Ramaswamy Narayanan said as he projected a cautiously optimistic outlook for the company.
GIC had reported a 43% rise in consolidated net profit in the first quarter. The company's bottom line came in at Rs 1,401 crore in the June quarter, compared to Rs 978 crore in the same period last year, according to an exchange filing.
Narayanan said that while the company outperformed its initial expectations, he anticipates a more stable growth trajectory. "The 15–16% growth rate we had initially projected remains our target for the full fiscal year. The high first quarter figures were partly due to some income being booked that might not recur in subsequent quarters," the managing director said in an interview with NDTV Profit.
Narayanan said GIC is aiming to achieve a total premium of Rs 42,000–43,000 crore by the end of the year. He acknowledged that the Q1 results were exceptional but emphasized that the company remains committed to its guidance.
The growth in the health sector, both group and retail, has been a significant driver for GIC. "Health insurance has shown remarkable growth, especially in the retail segment, which is now a focal point for us. This diversification is crucial as it helps balance out potential losses from other sectors, like catastrophic property and agriculture insurance," Narayanan said.
He expressed confidence in the sustainability of this growth, particularly in retail health insurance, which has seen increased demand post-Covid. "The pandemic has made it clear how important it is to have enough health insurance, which has increased demand for health insurance. This trend is expected to continue, presenting promising opportunities for reinsurance."
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.